John C. Bolger - Jun 1, 2021 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Role: Director
Signature: /s/ Paul Kim, as Attorney-in-fact
Stock symbol: FLGT
Transactions as of: Jun 1, 2021
Transactions value $: -$111,142
Form type: 4
Date filed: 6/3/2021, 05:41 PM
Previous filing: May 24, 2021
Next filing: Jun 7, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FLGT	Common Stock	Options Exercise	$1.23K	+313	+14.73%	$3.93^*	2.44K	Jun 1, 2021	Direct
transaction	FLGT	Common Stock	Options Exercise	$1.82K	+313	+12.84%	$5.81^*	2.75K	Jun 1, 2021	Direct
transaction	FLGT	Common Stock	Options Exercise	$19.8K	+1.25K	+45.44%	$15.82	4K	Jun 1, 2021	Direct
transaction	FLGT	Common Stock	Sale	-$134K	-1.88K	-46.89%	$71.41	2.13K	Jun 1, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FLGT	Stock Option (Right to Buy)	Options Exercise	$0	-313	-20.03%	$0.00	1.25K	Jun 1, 2021	Common Stock	313	$3.93	Direct	F2
transaction	FLGT	Stock Option (Right to Buy)	Options Exercise	$0	-313	-11.13%	$0.00	2.5K	Jun 1, 2021	Common Stock	313	$5.81	Direct	F3
transaction	FLGT	Stock Option (Right to Buy)	Options Exercise	$0	-1.25K	-25%	$0.00	3.75K	Jun 1, 2021	Common Stock	1.25K	$15.82	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were sold in multiple transactions at prices ranging from $71.2781 to $71.4784, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F2	The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date.
F3	The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date.
F4	The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 27, 2020, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date.